These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33187107)

  • 1. Novel Positive Allosteric Modulators of µ Opioid Receptor-Insight from In Silico and In Vivo Studies.
    Bartuzi D; Kędzierska E; Kaczor AA; Schmidhammer H; Matosiuk D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2015 Nov; 55(11):2421-34. PubMed ID: 26517559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.
    Kandasamy R; Hillhouse TM; Livingston KE; Kochan KE; Meurice C; Eans SO; Li MH; White AD; Roques BP; McLaughlin JP; Ingram SL; Burford NT; Alt A; Traynor JR
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning Down the Pain - An Overview of Allosteric Modulation of Opioid Receptors: Mechanisms of Modulation, Allosteric Sites, Modulator Syntheses.
    Bartuzi D; Wróbel TM; Kaczor AA; Matosiuk D
    Curr Top Med Chem; 2020; 20(31):2852-2865. PubMed ID: 32479245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.
    Remesic M; Hruby VJ; Porreca F; Lee YS
    ACS Chem Neurosci; 2017 Jun; 8(6):1147-1158. PubMed ID: 28368571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.
    Burford NT; Traynor JR; Alt A
    Br J Pharmacol; 2015 Jan; 172(2):277-86. PubMed ID: 24460691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effects of potent, selective and brain penetrant muscarinic M
    Grauer SM; Sanoja R; Poulin D; Rashid H; Jochnowitz N; Calhoun M; Zwilling D; Varty GB; Rosahl TW; Meziane H; Mittlelhaeuser C; Mazzola R; Morrow J; Smith SM; Henze D; Marcus J
    Brain Res; 2020 Jun; 1737():146814. PubMed ID: 32234514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects.
    Pryce KD; Kang HJ; Sakloth F; Liu Y; Khan S; Toth K; Kapoor A; Nicolais A; Che T; Qin L; Bertherat F; Kaniskan HÜ; Jin J; Cameron MD; Roth BL; Zachariou V; Filizola M
    Neuropharmacology; 2021 Sep; 195():108673. PubMed ID: 34153316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.
    Livingston KE; Traynor JR
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18369-74. PubMed ID: 25489080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor.
    Burford NT; Clark MJ; Wehrman TS; Gerritz SW; Banks M; O'Connell J; Traynor JR; Alt A
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10830-5. PubMed ID: 23754417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
    Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
    Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.
    Livingston KE; Stanczyk MA; Burford NT; Alt A; Canals M; Traynor JR
    Mol Pharmacol; 2018 Feb; 93(2):157-167. PubMed ID: 29233847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.
    Burford NT; Wehrman T; Bassoni D; O'Connell J; Banks M; Zhang L; Alt A
    J Biomol Screen; 2014 Oct; 19(9):1255-65. PubMed ID: 25047277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Insights into Mu Opioid Pharmacology.
    Pasternak GW; Childers SR; Pan YX
    Handb Exp Pharmacol; 2020; 258():89-125. PubMed ID: 31598835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.